NIH-funded research U01 cooperative agreement

Using hyperbaric oxygen to treat severe brain injuries

Official title: Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCC

Funded at Hennepin Healthcare Research Institute · NIH-11005150 · Data updated 2026-11-12

This study is looking at how breathing in extra oxygen can help people with severe brain injuries feel better and recover, and it’s designed for those who have experienced a serious traumatic brain injury.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionHennepin Healthcare Research Institute
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startJanuary 1, 2024
Project endJune 30, 2025
Funding year2024
Award (this year)$626,120
NIH project number3U01NS095926-05S1
Project IDNIH-11005150 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced severe traumatic brain injuries.

Less likely to help

Patients with mild brain injuries or those who do not have access to hyperbaric oxygen therapy may not benefit from this research.

What this research studies

This research investigates the effects of hyperbaric oxygen therapy on patients with severe traumatic brain injury (TBI). The approach involves administering increased oxygen levels to the brain to counteract cellular energy failure and reduce brain cell death. The study aims to optimize treatment parameters, such as pressure and frequency, to maximize benefits while minimizing risks of oxygen toxicity. By gathering critical data, this trial will help inform a larger phase III study on the efficacy of hyperbaric oxygen therapy for TBI patients.

Why it matters

Potential benefit: If successful, this research could lead to improved recovery outcomes for patients suffering from severe traumatic brain injuries.

How similar studies have gone: Previous studies have shown promising results for hyperbaric oxygen therapy in improving outcomes for brain injury patients, indicating potential for success in this approach.

Where this research is happening

  • Hennepin Healthcare Research Institute
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Rockswold, Gaylan L — Hennepin Healthcare Research Institute
  • Study coordinator: Rockswold, Gaylan L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.